omniture
logo
Search
APRINOIA Therapeutics 苏州新旭医药有限公司
Media Room

Latest News

rss

APRINOIA Therapeutics received FDA clearance to initiate APNmAb005 Phase 1 clinical trial

BOSTON, April 11, 2022 /PRNewswire/ -- APRINOIA Therapeutics announces today that the U.S. Food and...

2022-04-11 18:00 1198

APRINOIA Therapeutics Established Collaboration on Tau PET Imaging Tracer Development

TAIPEI, Dec. 16, 2020 /PRNewswire/ -- APRINOIA Therapeutics Inc. today announced that they had exec...

2020-12-16 08:00 2555

APRINOIA Announces Approval from NMPA to Initiate Phase 3 Clinical Trial in China for [18F]-APN-1607 Tau PET Imaging Tracer for Dementia

SUZHOU, China, Oct. 28, 2020 /PRNewswire/ -- APRINOIA Therapeutics announced today that China Natio...

2020-10-28 14:00 1946